Northern Trust
MAIA icon

Northern Trust’s MAIA Biotechnology MAIA Stock Holding History

Northern Trust’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Buy
125,171
+72,632
+138% +$96.5K ﹤0.01% 3964
2026
Q1 		$73.6K Buy
52,539
+13,507
+35% +$24.9K ﹤0.01% 4171
2025
Q4 		$59.7K Hold
39,032
– – ﹤0.01% 4244
2025
Q3 		$60.1K Hold
39,032
– – ﹤0.01% 4249
2025
Q2 		$70.3K Hold
39,032
– – ﹤0.01% 4178
2025
Q1 		$59.7K Buy
39,032
+6,961
+22% +$12.9K ﹤0.01% 4206
2024
Q4 		$63.5K Hold
32,071
– – ﹤0.01% 4232
2024
Q3 		$90.1K Hold
32,071
– – ﹤0.01% 4083
2024
Q2 		$110K Buy
32,071
+11,798
+58% +$37.2K ﹤0.01% 4029
2024
Q1 		$44.6K Hold
20,273
– – ﹤0.01% 4244
2023
Q4 		$23.7K Buy
+20,273
New +$32.7K ﹤0.01% 4343

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust's MAIA Position: Q2 2026 in Review

Northern Trust increased its MAIA Biotechnology (MAIA) stake by 138% in Q2 2026, buying an estimated $96.5K and bringing the position to 125,171 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3964.

Northern Trust first reported a position in MAIA in Q4 2023 and has held it in 11 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Northern Trust held 125,171 shares of MAIA Biotechnology worth $180K as of Q2 2026.
  • Northern Trust bought 72,632 MAIA Biotechnology shares in Q2 2026, an estimated $96.5K.
  • MAIA Biotechnology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3964 holding.
  • Northern Trust first reported a position in MAIA Biotechnology in Q4 2023 and has held it in 11 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.